HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Resistance to erucic acid as a selectable marker for peroxisomal activity: isolation of revertants of an infantile Refsum disease cell line.

Abstract
A system based on the ability of cells to oxidize very long-chain fatty acids (VLCFA) was developed to select in vitro normal human fibroblasts from fibroblasts of patients suffering from peroxisomal disorders with multienzymatic deficiencies: Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease (IRD). Cells treated with various concentrations of erucic acid (C22:1 n-9) revealed an enhanced toxicity of this fatty acid for the fibroblasts of patients compared with normal cells. This differential toxicity is correlated with variable accumulations of C22:1 n-9 and the absence of beta-oxidation products in the mutants. Revertants from clonal IRD cell lines were isolated in the selective medium at frequencies ranging from 3 x 10(-7) to 4 x 10(-6) depending on the line. After six weeks of growth in the absence of selective pressure, the variants exhibited a resistance level to C22:1 n-9 identical to that of normal cells. Furthermore, beta-oxidation of VLCFA is re-established in these selected cells as well as dihydroxyacetone phosphate acyltransferase activity. Immunoblot experiments also demonstrated a restored pattern of acyl-CoA oxidase molecular forms. Last, immunofluorescence studies revealed the presence of cytoplasmic structures that were absent in the original IRD cells. Thus, both the deficiencies in metabolic pathways and paucity of the organelle are at least partially corrected in the selected clones.
AuthorsE Bachir Bioukar, F Straehli, K H Ng, M O Rolland, T Hashimoto, J P Carreau, J Deschatrette
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 17 Issue 1 Pg. 41-59 ( 1994) ISSN: 0141-8955 [Print] United States
PMID7519689 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Albumins
  • Biomarkers
  • Erucic Acids
  • Lipids
  • erucic acid
  • DNA
  • Acyltransferases
  • glycerone-phosphate O-acyltransferase
Topics
  • Acyltransferases (metabolism)
  • Albumins (chemistry)
  • Autoradiography
  • Biomarkers
  • Cell Line
  • DNA (analysis, isolation & purification)
  • Erucic Acids (chemistry, pharmacology)
  • Fibroblasts
  • Fluorescent Antibody Technique
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Infant, Newborn
  • Lipids (analysis, isolation & purification)
  • Microbodies (metabolism)
  • Mutation
  • Refsum Disease (genetics, metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: